Asthma care that notices your rescue inhaler is climbing before you do.
Clara's AI watches your rescue-inhaler use and allergy triggers, then builds a plan that updates as your asthma shifts.
Guideline-aligned asthma care, tuned to your chart and your refill history.
Tell Clara how your asthma is going
Describe symptoms, rescue-inhaler use in the last month, nighttime coughing, exercise limits, and triggers. Clara auto-pulls your refill history, prior spirometry, allergy diagnoses, and current controller regimen from 150,000+ connected records.
AI applies GINA step-up / step-down logic
Clara grades your control (well-controlled, partly, uncontrolled) against GINA criteria1, then recommends step-up, step-down, or switch-track adjustments. It cross-checks pregnancy, age, beta-blocker use, and cardiac history before any long-acting beta agonist.
Clinical sign-off or escalation
A licensed physician reviews the plan and signs prescriptions. If your asthma is severe, frequently exacerbating, or not responding to high-dose ICS–LABA, Clara refers you to pulmonology and keeps the plan coordinated.
Peak flow, rescue use, and your chart. Step-up decisions based on all three.
Controller + reliever, chosen against your pattern.
Budesonide/formoterol (ICS–formoterol)
Low-dose inhaled corticosteroid plus fast-onset LABA, used as both maintenance and reliever (MART / AIR). GINA's preferred track 1 for adults and adolescents with mild-to-moderate asthma1. Replaces “just an albuterol inhaler” for most patients with symptoms more than twice a month.
Inhaled corticosteroids (ICS)
Fluticasone propionate or budesonide alone for track-2 regimens or patients whose pattern favors a fixed daily controller plus separate albuterol reliever. Clara picks between track 1 and track 2 based on adherence patterns and prior response.
Albuterol (SABA) rescue inhaler
Short-acting bronchodilator for symptom relief in patients on a track-2 ICS regimen, or as backup. GINA and the FDA label both warn against SABA monotherapy for persistent asthma — if you're refilling albuterol more than once every 2–3 months, your controller plan needs attention2. See the albuterol page for detail.
ICS–LABA step-up (e.g., fluticasone/salmeterol)
For patients on medium-dose ICS who remain uncontrolled, a twice-daily ICS–LABA combo is an evidence-based step-up. Clara checks your chart for prior trials and adjusts before adding a second controller.
Montelukast (Singulair)
10 mg daily. Useful when asthma overlaps with allergic rhinitis, exercise-induced bronchoconstriction, or aspirin-exacerbated respiratory disease. Carries an FDA boxed warning for neuropsychiatric effects4; Clara discusses this before any prescription.
When Clara sends you in
Severe exacerbation (can't speak in full sentences, RR >30, O₂ sat <92%, peak flow <50% of personal best), suspected pneumonia, a step-4/step-5 regimen not controlling symptoms, or biologic-eligible severe asthma all warrant in-person care or pulmonology. Clara coordinates the referral rather than prescribing through it.
An asthma visit that knows your rescue-inhaler refill history before it starts.
| Clara | Teladoc | CVS MinuteClinic Virtual | GoodRx coupon only | Your doctor | |
|---|---|---|---|---|---|
| AI response time | Instant, 24/7 | Scheduled video | Clinic hours | Coupon — no provider | Days–weeks |
| Reads your refill history & rescue use | Intake only | Portions of records | ✗ | If your PCP | |
| GINA-aligned step-up / step-down logic | AI-applied | Provider-dependent | Provider-dependent | ✗ | Provider-dependent |
| Coordinates asthma ↔ allergy plans | One AI, one plan | Different visit | Different visit | ✗ | If your PCP |
| Cost of care | Free to start; $25/mo membership for Rx & labs | Variable, often via employer | $107–$164 out of pocket per visit | No visit — Rx only | $150+ copay |
| Prescription may be covered by your insurance | Sent to your pharmacy | Cash coupon only | |||
| Spots a worsening pattern before the next ED visit | ✗ | ✗ | ✗ | Maybe at annual visit |
GINA step-up, step-down, or switch-track. Run on your actual data, every time.
Asthma is a pattern disease. It rewards the reader who actually looks at the pattern.
Your last three albuterol refills are a claim about how controlled your asthma is. GINA has been explicit since 2019 that SABA-only asthma is not the right answer. The gap isn't the guideline — it's that nobody is reading your whole chart every time.
Reads your refill history every time
Clara notices that you've refilled albuterol three times since January and your last ICS refill was 9 months ago. Your old doctor may see that once a year at a 15-minute visit; Clara sees it every message.
Applies GINA track 1 vs track 2 to your data
Is ICS–formoterol MART the right move, or are you an adherence-to-a-daily-controller patient better served by track 2? Clara reasons through your adherence pattern, trigger profile, and prior response, then hands off to our doctor.
Spots the escalation before the ED
Five albuterol refills in a quarter plus a pollen spike plus a respiratory virus is a predictable setup for an exacerbation. Clara flags the pattern early and steps therapy up rather than waiting for the urgent care visit.
See the trend coming. Step therapy up before the next ED visit.
Common questions
Asthma questions patients ask.
What does Clara cost?
How is Clara different from Teladoc, CVS MinuteClinic, or my regular doctor?
Isn't albuterol alone enough for mild asthma?
What counts as "uncontrolled" asthma?
Can Clara treat a current asthma attack?
Are my allergies making my asthma worse?
Does Clara order spirometry?
Is Clara a real medical practice?
Can I use Clara for other health issues too?
An AI asthma plan that reads your refill history first.
Connect your records for free. See what an asthma visit looks like when the AI already knows how many rescue refills you've had this quarter and when your allergy season starts.
Get startedClara manages mild-to-moderate persistent asthma. Severe or life-threatening exacerbations, severe persistent asthma requiring biologics, and pediatric asthma require in-person evaluation and, when appropriate, pulmonology referral. Montelukast (Singulair) carries an FDA boxed warning for serious mental health side effects. Albuterol and other SABAs should not be used as monotherapy for persistent asthma per GINA. Ventolin, ProAir, Proventil, Symbicort, Advair, Flovent, and Singulair are registered trademarks of their respective owners.
For important safety information about the medications discussed on this page, see the FDA prescribing information: budesonide/formoterol (Symbicort), fluticasone propionate (Flovent), fluticasone/salmeterol (Advair), albuterol (Ventolin, ProAir), montelukast (Singulair).
1Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2024 update. GINA Track 1 (ICS–formoterol as both controller and reliever) is the preferred treatment pathway for adults and adolescents with mild-to-moderate asthma; SABA-only treatment is no longer recommended for persistent asthma. View the GINA report.
2U.S. Food & Drug Administration. Prescribing information for albuterol sulfate inhalation aerosol (Ventolin HFA, ProAir HFA, Proventil HFA). DailyMed: albuterol prescribing information.
3GoodRx. Asthma inhalers savings list. Accessed 2026-04-21: “Generic Proventil HFA (6.7g): As low as $19.00–$19.45. Generic ProAir HFA (8.5g): As low as $23.00–$23.76. Generic Ventolin HFA (18g): As low as $32.10.” View on GoodRx.
4U.S. Food & Drug Administration. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair). March 2020. Read the FDA safety communication.